Omitting Therapeutic Lymph Node Dissection in Patients With Melanoma (Stage 3) and Major Pathological Response in the Index Lymph Node
NCT06754904
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
213
Enrollment
OTHER
Sponsor class
Conditions
Melanoma, Skin
Interventions
PROCEDURE:
Omitting TLND
PROCEDURE:
Index node procedure
Sponsor
D.J. (Dirk) Grünhagen